Insulin inhibits Abeta fibrillogenesis through a decrease of the GM1 ganglioside-rich microdomain in neuronal membranes

J Neurochem. 2010 May;113(3):628-36. doi: 10.1111/j.1471-4159.2010.06620.x. Epub 2010 Jan 28.

Abstract

Type 2 diabetes is a risk factor for late-onset Alzheimer's disease. However, the underlying mechanisms remain unknown. To investigate whether insulin is associated with the assembly of amyloid beta-protein from the cell surface, we treated nerve growth factor (NGF)-treated rat pheochromocytoma 12 (PC12) cells with insulin, which is related to the development of diabetes. Insulin treatment induced a decrease in GM1 ganglioside (GM1) levels in detergent-resistant membrane microdomains of NGF-treated PC12 cells. The insulin-induced effects on GM1 levels were regulated by a phosphatidylinositol 3-kinase inhibitor, but not by an extracellular signal-regulated kinase inhibitor. Pre-treatment with a protein synthesis inhibitor did not inhibit the decrease in GM1 levels induced by insulin. In addition, insulin failed to induce formation of fibrils from soluble amyloid beta-protein or to accelerate GM1-induced fibril formation. Furthermore, assembly of amyloid beta-protein in cultures of NGF-treated PC12 cells was significantly decreased by insulin. These results suggest that insulin inhibits amyloid beta-protein assembly by decreasing GM1 expression in detergent-resistant membrane microdomains of neuronal membranes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / biosynthesis
  • Amyloid beta-Peptides / antagonists & inhibitors*
  • Amyloid beta-Peptides / toxicity*
  • Animals
  • Blotting, Western
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Chloroquine / pharmacology
  • Cycloheximide / pharmacology
  • Electrophoresis, Polyacrylamide Gel
  • Fluorescent Dyes
  • G(M1) Ganglioside / metabolism*
  • Homeostasis / drug effects
  • Hypoglycemic Agents / antagonists & inhibitors
  • Hypoglycemic Agents / pharmacology*
  • Insulin / pharmacology*
  • Liposomes
  • Morpholines / pharmacology
  • Neurofibrillary Tangles / drug effects*
  • Neurons / drug effects
  • Neurons / metabolism*
  • PC12 Cells
  • Phosphatidylinositol 3-Kinases / metabolism
  • Protein Synthesis Inhibitors / pharmacology
  • Rats

Substances

  • Actins
  • Amyloid beta-Peptides
  • Fluorescent Dyes
  • Hypoglycemic Agents
  • Insulin
  • Liposomes
  • Morpholines
  • Protein Synthesis Inhibitors
  • G(M1) Ganglioside
  • RV 538
  • Chloroquine
  • Cycloheximide
  • Phosphatidylinositol 3-Kinases